| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |